STAT
As FDA misses deadline on electric shock ban, disability advocates speak out
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual…
health · source
STAT News on WeSearch
Recent health headlines from STAT News.
STAT
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast”…
STAT
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall…
STAT
CDC says containing the spread of Ebola is top priority
The CDC has emphasized that containing the Ebola outbreak in the Democratic Republic of Congo and Uganda is its top…
STAT
STAT+: A turning point for pancreatic cancer patients
Recent advancements in pancreatic cancer treatment have been highlighted, particularly the promising results of…
STAT
STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55…
STAT
STAT+: A standing ovation for RevMed, and caution for Akeso
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
STAT
STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse…
STAT
STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug
Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in…
STAT News
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
STAT News
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and…
STAT
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
STAT News
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.
STAT News
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
At the ASCO annual meeting, Bristol-Myers Squibb presented positive data regarding its treatment for multiple myeloma.…
STAT News
STAT+: Allogene CEO David Chang stepping down
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news…
STAT News
Which vaccines will curb the Ebola outbreak? WHO debates
The WHO is currently debating which vaccines and therapeutics should be tested to combat the ongoing Bundibugyo Ebola…
STAT News
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical…
STAT
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
STAT
STAT+: The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of…
STAT
STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
Biotech veteran Jeremy Levin discusses the future of the biotech industry and the challenges it faces. He highlights…
STAT
An ASCO preview: What to watch for at cancer research’s big meeting
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
STAT News
STAT+: Heart patch engineered from stem cells revved up weakened hearts
A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step,"…
STAT News
Kailera’s own ‘triple-G’ drug also looks very powerful
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
STAT
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel…
STAT
Trump says latest medical exam went ‘PERFECTLY’
The conference where death is (theoretically) optional, new trends among undocumented patients, and more health news…
STAT News
Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children
Senator Dick Durbin criticizes the Trump administration for allowing flavored e-cigarettes that target children. He…
STAT News
Opinion: The patients demanding unvaccinated blood transfusions
Some patients are requesting blood transfusions from unvaccinated donors due to concerns fueled by misinformation…
STAT News
STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption
Stanford University is actively involving patients in the development of artificial intelligence tools for healthcare.…
STAT News
‘Are we just going to give up and die like every other generation?’
The Vitalist Bay longevity conference in Berkeley, California, gathered around 100 attendees to explore advancements…
STAT News
Opinion: It’s the end of science as we know it, and I feel fine
“Science itself is inherently resilient — that is, after all, why it’s science,” writes Jonathan Jackson.
STAT News
Trump is seeing doctors for his annual physical. What the public finds out is up to him
President Trump is getting a medical exam on Tuesday, putting his health under renewed public scrutiny after he has…
STAT News
What do early data from Utah’s Doctronic AI pilot show?
Utah has released early data from its pilot program using Doctronic's AI chatbot for prescription renewals. The AI…
STAT
Ebola outbreak continues to worsen, with new collateral risks for girls and women
The Ebola outbreak in the Democratic Republic of Congo is worsening, with 101 confirmed cases and over 900 suspected…
STAT
STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a…
STAT News
STAT+: Eli Lilly to buy three small vaccine developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field…
STAT News
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a…
STAT News
Opinion: The Ebola outbreak will lead to devastating violence against women and girls
“Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write…
STAT News
Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write…
STAT News
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in…
STAT News
Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies
“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in…
STAT
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants…
STAT News
Opinion: How the perimenopause movement is hurting women
The perimenopause movement is criticized for portraying women as victims of their hormones, according to experts…
STAT News
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
Hospitals and other providers are bracing for an end to the extra money they’ve gotten for treating Medicaid patients,…
STAT
A CDC page on mpox caught in political crosshairs
Seed oil panic, how STIs spread, and more health news from Morning Rounds
STAT
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a…
STAT News
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion…
STAT News
A federal office of men’s health has never been closer, yet it’s likely still years away
The establishment of a federal office of men's health is gaining bipartisan support but is still likely years away.…
STAT News
STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington
How a pharma company is soliciting research that can be used to blunt pharma proposed reforms in Washington.
STAT News
Opinion: Check-in and intake at the doctor’s office are perfect for AI
The author argues that the check-in and intake process at medical offices could be improved with the use of AI…
STAT News
Opinion: The seed oil panic is hurting my cardiac patients
The article discusses the negative impact of the seed oil panic on cardiac patients. It argues that vegetable oils,…
How WeSearch handles this source
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.
Indexing: Allowed
Snippet: Allowed
AI summary: Limited
Retrieval / RAG: Not asserted
Model training: Not asserted
Commercial reuse: Not permitted